• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碳酸酐酶的皮摩尔级抑制剂:抑制和结合测定的重要性

Picomolar inhibitors of carbonic anhydrase: Importance of inhibition and binding assays.

作者信息

Smirnovienė Joana, Smirnovas Vytautas, Matulis Daumantas

机构信息

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio al. 7, LT-10257 Vilnius, Lithuania.

出版信息

Anal Biochem. 2017 Apr 1;522:61-72. doi: 10.1016/j.ab.2017.01.022. Epub 2017 Jan 31.

DOI:10.1016/j.ab.2017.01.022
PMID:28153585
Abstract

The K of carbonic anhydrase (CA) inhibitors is often determined by the stopped- flow CO hydration assay, the method that directly follows the inhibition of CA enzymatic activity. However, the assay has limitations, such as largely unknown concentration of CO and the inability to determine the K below several nM. The widely used direct binding assay, isothermal titration calorimetry, also does not determine the K below several nM. In contrast, the thermal shift assay can accurately determine picomolar affinities. New equations estimating CO concentration were developed for the determination of k and K of CA I and CA II. The inhibitor dose-response curves were analyzed using Hill and Morrison equations demonstrating that only the Morrison model is applicable for the determination of tight-binding inhibitor K. The measurements of interactions between ten inhibitors and seven CA isoforms showed the limitations and advantages of all three techniques. Inhibitor 6 exhibited the K of 50 pM and was highly selective towards human CA IX, an isoform which is nearly absent in healthy human, but highly overexpressed in numerous cancers. Combination of inhibition and binding techniques was necessary for precise determination of CA-high-affinity inhibitor interactions and future drug design.

摘要

碳酸酐酶(CA)抑制剂的解离常数(K)通常通过停流CO水合测定法来确定,该方法可直接监测CA酶活性的抑制情况。然而,该测定法存在局限性,比如CO浓度大多未知,且无法测定低于几纳摩尔的K值。广泛使用的直接结合测定法——等温滴定量热法,也无法测定低于几纳摩尔的K值。相比之下,热位移测定法能够准确测定皮摩尔亲和力。为了测定CA I和CA II的k值和K值,开发了估算CO浓度的新方程。使用希尔方程和莫里森方程分析抑制剂剂量反应曲线,结果表明只有莫里森模型适用于测定紧密结合抑制剂的K值。对十种抑制剂与七种CA同工型之间相互作用的测量显示了这三种技术的局限性和优势。抑制剂6的K值为50皮摩尔,对人CA IX具有高度选择性,CA IX在健康人体内几乎不存在,但在多种癌症中高度过表达。抑制和结合技术的结合对于精确测定CA高亲和力抑制剂相互作用以及未来的药物设计是必要的。

相似文献

1
Picomolar inhibitors of carbonic anhydrase: Importance of inhibition and binding assays.碳酸酐酶的皮摩尔级抑制剂:抑制和结合测定的重要性
Anal Biochem. 2017 Apr 1;522:61-72. doi: 10.1016/j.ab.2017.01.022. Epub 2017 Jan 31.
2
Thermodynamic, kinetic, and structural parameterization of human carbonic anhydrase interactions toward enhanced inhibitor design.针对增强抑制剂设计的人碳酸酐酶相互作用的热力学、动力学和结构参数化。
Q Rev Biophys. 2018 Jan;51:e10. doi: 10.1017/S0033583518000082.
3
Inhibition and binding studies of carbonic anhydrase isozymes I, II and IX with benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulphonamides.苯并咪唑[1,2-c][1,2,3]噻二唑-7-磺酰胺类化合物对碳酸酐酶同工酶 I、II 和 IX 的抑制和结合研究。
J Enzyme Inhib Med Chem. 2010 Dec;25(6):863-70. doi: 10.3109/14756360903571685. Epub 2010 Feb 18.
4
Probing the 'bipolar' nature of the carbonic anhydrase active site: aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms.探究碳酸酐酶活性位点的“双极性”本质:含1,3-恶唑-5-基部分的芳基磺酰胺作为胞质碳酸酐酶I和II同工型的皮摩尔级抑制剂
Eur J Med Chem. 2015 Aug 28;101:334-47. doi: 10.1016/j.ejmech.2015.06.022. Epub 2015 Jun 25.
5
Investigation of arenesulfonyl-2-imidazolidinones as potent carbonic anhydrase inhibitors.对芳基磺酰基-2-咪唑啉酮作为强效碳酸酐酶抑制剂的研究。
J Enzyme Inhib Med Chem. 2015 Feb;30(1):81-4. doi: 10.3109/14756366.2014.880696. Epub 2014 Mar 25.
6
Intrinsic thermodynamics of inhibitor binding to human carbonic anhydrase IX.抑制剂与人类碳酸酐酶IX结合的内在热力学
Biochim Biophys Acta. 2016 Apr;1860(4):708-18. doi: 10.1016/j.bbagen.2016.01.007. Epub 2016 Jan 18.
7
Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.碳酸酐酶抑制剂。含色酮和芳族磺酰胺部分的席夫碱及其锌配合物对胞质/肿瘤相关碳酸酐酶同工酶I、II、IX和XII的抑制作用。
Bioorg Med Chem Lett. 2005 Jun 15;15(12):3096-101. doi: 10.1016/j.bmcl.2005.04.055.
8
Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases.研究布林佐胺和多佐胺与人碳酸酐酶相互作用的结构。
Bioorg Med Chem. 2013 Nov 15;21(22):7210-5. doi: 10.1016/j.bmc.2013.08.033. Epub 2013 Aug 28.
9
Inhibitory effects of nitrite on the reactions of bovine carbonic anhydrase II with CO2 and bicarbonate consistent with zinc-bound nitrite.亚硝酸盐对牛碳酸酐酶II与二氧化碳和碳酸氢盐反应的抑制作用,与锌结合的亚硝酸盐一致。
J Inorg Biochem. 2015 Aug;149:6-11. doi: 10.1016/j.jinorgbio.2015.04.013. Epub 2015 Apr 27.
10
Functionalization of fluorinated benzenesulfonamides and their inhibitory properties toward carbonic anhydrases.氟化苯磺酰胺的功能化及其对碳酸酐酶的抑制特性。
ChemMedChem. 2015 Apr;10(4):662-87. doi: 10.1002/cmdc.201402490. Epub 2015 Mar 10.

引用本文的文献

1
Affinity and Selectivity of Protein-Ligand Recognition: A Minor Chemical Modification Changes Carbonic Anhydrase Binding Profile.蛋白质-配体识别的亲和力与选择性:微小化学修饰改变碳酸酐酶的结合模式。
J Med Chem. 2025 Aug 28;68(16):17752-17773. doi: 10.1021/acs.jmedchem.5c01421. Epub 2025 Aug 13.
2
From X-ray crystallographic structure to intrinsic thermodynamics of protein-ligand binding using carbonic anhydrase isozymes as a model system.从 X 射线晶体结构到碳酸酐酶同工酶模型系统中蛋白质 - 配体结合的固有热力学。
IUCrJ. 2024 Jul 1;11(Pt 4):556-569. doi: 10.1107/S2052252524004627.
3
PLBD: protein-ligand binding database of thermodynamic and kinetic intrinsic parameters.
PLBD:热力学和动力学内在参数的蛋白质-配体结合数据库。
Database (Oxford). 2023 Jun 8;2023. doi: 10.1093/database/baad040.
4
Picomolar fluorescent probes for compound affinity determination to carbonic anhydrase IX expressed in live cancer cells.用于测定活癌细胞中表达的碳酸酐酶 IX 与化合物亲和力的皮摩尔荧光探针。
Sci Rep. 2022 Oct 21;12(1):17644. doi: 10.1038/s41598-022-22436-1.
5
Structure and mechanism of secondary sulfonamide binding to carbonic anhydrases.磺胺类药物与碳酸酐酶结合的结构与机制。
Eur Biophys J. 2021 Oct;50(7):993-1011. doi: 10.1007/s00249-021-01561-1. Epub 2021 Jul 30.
6
Switching the Inhibitor-Enzyme Recognition Profile via Chimeric Carbonic Anhydrase XII.通过嵌合碳酸酐酶 XII 切换抑制剂-酶识别谱。
ChemistryOpen. 2021 May;10(5):567-580. doi: 10.1002/open.202100042.
7
A standard operating procedure for an enzymatic activity inhibition assay.一种酶活性抑制检测的标准操作程序。
Eur Biophys J. 2021 May;50(3-4):345-352. doi: 10.1007/s00249-021-01530-8. Epub 2021 Apr 16.
8
Uncertainty in protein-ligand binding constants: asymmetric confidence intervals versus standard errors.蛋白质 - 配体结合常数的不确定性:不对称置信区间与标准误差。
Eur Biophys J. 2021 May;50(3-4):661-670. doi: 10.1007/s00249-021-01518-4. Epub 2021 Apr 10.
9
Isoform-Selective Enzyme Inhibitors by Exploring Pocket Size According to the Lock-and-Key Principle.根据锁钥原理探索口袋大小的同工酶选择性抑制剂。
Biophys J. 2020 Oct 20;119(8):1513-1524. doi: 10.1016/j.bpj.2020.08.037. Epub 2020 Sep 9.
10
Engineered Carbonic Anhydrase VI-Mimic Enzyme Switched the Structure and Affinities of Inhibitors.工程化碳酸酐酶 VI 模拟酶改变抑制剂的结构和亲和力。
Sci Rep. 2019 Sep 3;9(1):12710. doi: 10.1038/s41598-019-49094-0.